Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation.
Saved in:
| Title: | Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation. |
|---|---|
| Authors: | Wood MD; Department of Pathology, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Neff T; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Nickerson JP; Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR, USA., Sayama C; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA., Raslan AM; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA., Ambady P; Department of Neurology, Oregon Health & Science University, Portland, OR, USA., Corless CL; Department of Pathology, Oregon Health & Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Nazemi KJ; Department of Pediatrics, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR, USA. |
| Source: | Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2021 Apr; Vol. 47 (3), pp. 460-463. Date of Electronic Publication: 2020 Dec 20. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7609829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2990 (Electronic) Linking ISSN: 03051846 NLM ISO Abbreviation: Neuropathol Appl Neurobiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
